Lakefront Biotherapeutics | GLPG - Ebitda





Ebitda Perubahan Tanggal
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Incyte USD 367.97M 46.53M 2026-03
Merck EUR 1.53B 87M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03